Invention Grant
- Patent Title: Sepiapterin reductase inhibitors
-
Application No.: US15282000Application Date: 2016-09-30
-
Publication No.: US09963462B2Publication Date: 2018-05-08
- Inventor: Mark Joseph Tebbe , Holly Victoria Atton , Craig Avery , Steven Mark Bromidge , Mark Kerry , Adrian Kotei Kotey , Nathaniel J. Monck , Mirco Meniconi , Mark Peter Ridgill , Heather Tye , Eddine Saiah , Kai Peter Johnsson , Katarzyna Irena Gorska , Hairuo Peng , John Michael McCall
- Applicant: QUARTET MEDICINE, INC. , ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
- Applicant Address: DE München
- Assignee: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Current Assignee: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
- Current Assignee Address: DE München
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D403/14 ; C07D495/04 ; C07D401/14 ; C07D471/04 ; C07D487/08 ; C07D491/107 ; C07D487/10 ; C07D487/04 ; C07D413/14 ; C07D451/02
Abstract:
Inhibitors of sepiapterin reductase and uses of sepiapterin reductase inhibitors in analgesia, treatment of acute and chronic pain, anti-inflammation, and immune cell regulation are disclosed.
Public/Granted literature
- US20170096435A1 SEPIAPTERIN REDUCTASE INHIBITORS Public/Granted day:2017-04-06
Information query
